fren

Nadine Beauger , Ph.D., MBA, President and Chief Executive Officer, IRICoR

Dr. Nadine Beauger is President and CEO of IRICoR, a Centre of Excellence in Commercialization and Research specializing in drug discovery in oncology and related areas, based at IRIC/University of Montreal. Under her leadership, IRICoR has raised significant funding through federal and provincial government programs among other sources, broadened its portfolio of projects across Canada, concluded multi-million$ collaborations with international biopharmaceutical partners and contributed to the creation of successful spin-off companies.

Dr. Beauger began her career as a Patent Consultant at Robic, a Montreal-based IP boutique, where she undertook drafting, prosecution and IP strategic management for national and international biotech clients. She went on as Associate at VantagePoint Venture Partners, a leading California-headquartered venture capital firm with more than $4 billion under management. Just prior to joining IRICoR, Dr. Beauger was Business Development Manager at Paladin Labs Inc, a top specialty pharmaceutical company based in Montreal (now an Endo international company).

She holds a Ph.D. in Biomedical Sciences (Hematology and Oncology), an M.Sc. in Cellular Biopathology from Université de Montréal and a B.Sc. in Anatomy from McGill University. She also holds an MBA degree from HEC Montréal (Excellence Studentship Award and Best Speaker Award). Dr. Beauger has been an invited speaker at a number of national and international events. She sits as director on a number of boards (private companies and not-for-profit organizations).